Curcuma Forte 60t
Couldn't load pickup availability
Description:
Comprehensive Joint Support with Curcuma Active
Curcuma Active is expertly formulated with a powerful combination of all three curcuminoids found in Turmeric, including curcumin, demethoxycurcumin, and bisdemethoxycurcumin. These are bound to a Sunflower oil-derived Curcumin-Phospholipid Complex, enhancing absorption and bioavailability. This potent formula supports joint mobility and flexibility, reduces mild joint swelling, and alleviates discomfort associated with mild arthritis. Additionally, Curcuma Active provides strong anti-inflammatory and antioxidant benefits, making it an essential supplement for maintaining joint health and overall well-being. Learn more about the benefits of curcumin in our blog.
Indications
- Supports joint mobility and flexibility and reduces mild joint swelling and stiffness associated with mild arthritis.
- Anti-inflammatory.
- Reduces mild rheumatic aches and pains.
- Decreases symptoms of mild arthritis, including mild joint pain.
- Maintains joint health.
- Antioxidant - reduces free radicals formed in the body.
Dose
Adults: Take 1 to 2 tablets daily.
Ingredients
| Each tablet contains: | |
| Curcuma longa phospholipid complex | 500 mg |
| Derived from rhizome fresh | 16.5 g |
| Standard to contain curcuminoids | 100 mg |
Allergen Information
- No Added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds, artificial sweeteners, colours or flavours.
- Vegan friendly.
Excipients
Calcium hydrogen phosphate dihydrate, colloidal anhydrous silica, croscarmellose sodium, crospovidone, hypromellose, lecithin (sunflower), magnesium stearate, microcrystalline cellulose, sodium starch glycollate.
Warnings
- Despite Turmeric and curcumin having low toxicity, caution is advised (due to the increased bioavailability) for the use of curcumin phospholipid complex during pregnancy, women wishing to conceive, and patients taking prescribed medications, such as those with a narrow therapeutic window and antiplatelet or anticoagulant drugs.
- Monitoring is advised for patients taking anti-inflammatory drugs, as the reduced dosage of the drug may be possible.
- Contraindicated in obstruction of the biliary tract, caution is advised in gallstones.
- Until more information is available regarding the expression of Nrf2 in cancer, do not take at least 48 hours on either side of each chemotherapy or radiotherapy treatment.
- Not to be used in children under five years of age.
- Discontinue 7 days prior to general anaesthesia.
- Caution in patients taking tacrolimus. Caution with long-term use in patients taking etoricoxib.
- If patient symptoms persist, seek additional professional advice.
